These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 9095206)

  • 41. Biophysical aspects of the integrated combination of cytostatic drugs with radiotherapy. Part 3: In vivo investigations on murine C3H mammary adenocarcinoma treated with cis-platinum, adriamycin, epirubicin, activated cyclophosphamide, activated isophosphamide and irradiation with 10 MeV electrons--verification of the therapeutic results with 31P-NMR spectroscopy.
    Ulmer W
    Strahlenther Onkol; 1991 Sep; 167(9):553-60. PubMed ID: 1925940
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potentiation of radiation-induced regrowth delay in murine tumors by fludarabine.
    Grégoire V; Hunter N; Milas L; Brock WA; Plunkett W; Hittelman WN
    Cancer Res; 1994 Jan; 54(2):468-74. PubMed ID: 8275483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A new syndrome: ascites, hyperbilirubinemia, and hypoalbuminemia after biochemical modulation of fluorouracil with N-phosphonacetyl-L-aspartate (PALA).
    Kemeny N; Seiter K; Martin D; Urmacher C; Niedzwiecki D; Kurtz RC; Costa P; Murray M
    Ann Intern Med; 1991 Dec; 115(12):946-51. PubMed ID: 1824554
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Purine analogue 6-methylmercaptopurine riboside inhibits early and late phases of the angiogenesis process.
    Presta M; Rusnati M; Belleri M; Morbidelli L; Ziche M; Ribatti D
    Cancer Res; 1999 May; 59(10):2417-24. PubMed ID: 10344752
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The effect of hypoxia and hyperoxia on nucleoside triphosphate/inorganic phosphate, pO2 and radiation response in an experimental tumour model.
    Nordsmark M; Maxwell RJ; Horsman MR; Bentzen SM; Overgaard J
    Br J Cancer; 1997; 76(11):1432-9. PubMed ID: 9400939
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chemotherapy-induced changes in the energetics of human breast cancer cells; 31P- and 13C-NMR studies.
    Neeman M; Eldar H; Rushkin E; Degani H
    Biochim Biophys Acta; 1990 May; 1052(2):255-63. PubMed ID: 2334736
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of N-(phosphonacetyl)-L-aspartate on 5-azacytidine metabolism in P388 and L1210 cells.
    Grant S; Rauscher F; Jakubowski A; Cadman E
    Cancer Res; 1981 Feb; 41(2):410-8. PubMed ID: 6160908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A phase I-II study of N-(phosphonacetyl)-L-aspartic acid (PALA) added to 5-fluorouracil and folinic acid in advanced colorectal cancer.
    Jodrell DI; Oster W; Kerr DJ; Canney PA; Yosef H; Steward WP; Kaye SB; Cassidy J
    Eur J Cancer; 1994; 30A(7):950-5. PubMed ID: 7946590
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A phase II study of the combination, 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) and N-(phosphonacetyl)-L-aspartate (PALA), in patients with advanced large bowel cancer.
    Rubin J; Schutt AJ; O'Connell MJ; Gertz MA; Moertel CG
    Am J Clin Oncol; 1984 Oct; 7(5):523-5. PubMed ID: 6507373
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Biochemical modulation of bolus fluorouracil by PALA in patients with advanced colorectal cancer.
    Kemeny N; Conti JA; Seiter K; Niedzwiecki D; Botet J; Martin D; Costa P; Wiseberg J; McCulloch W
    J Clin Oncol; 1992 May; 10(5):747-52. PubMed ID: 1569447
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Phase I and clinical pharmacological evaluation of biochemical modulation of 5-fluorouracil with N-(phosphonacetyl)-L-aspartic acid.
    Casper ES; Vale K; Williams LJ; Martin DS; Young CW
    Cancer Res; 1983 May; 43(5):2324-9. PubMed ID: 6831457
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Overview of N-(phosphonacetyl)-L-aspartate + fluorouracil in clinical trials.
    Martin DS; Kemeny NE
    Semin Oncol; 1992 Apr; 19(2 Suppl 3):228-33. PubMed ID: 1557654
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Potentiation of murine MCa-4 carcinoma radioresponse by 9-amino-20(S)-camptothecin.
    Kirichenko AV; Rich TA; Newman RA; Travis EL
    Cancer Res; 1997 May; 57(10):1929-33. PubMed ID: 9157987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. 31P NMR spectroscopy can predict the optimum interval between fractionated irradiation doses.
    Murata O; Sakurai H; Mitsuhashi N; Hasegawa M; Yamakawa M; Kurosaki H; Hayakawa K; Niibe H
    Anticancer Res; 1998; 18(6A):4297-301. PubMed ID: 9891481
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Hyaluronidase enhances the activity of adriamycin in breast cancer models in vitro and in vivo.
    Beckenlehner K; Bannke S; Spruss T; Bernhardt G; Schönenberg H; Schiess W
    J Cancer Res Clin Oncol; 1992; 118(8):591-6. PubMed ID: 1517281
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mechanism of resistance of variants of the Lewis lung carcinoma to N-(phosphonacetyl)-L-aspartic acid.
    Kensler TW; Mutter G; Hankerson JG; Reck LJ; Harley C; Han N; Ardalan B; Cysyk RL; Johnson RK; Jayaram HN; Cooney DA
    Cancer Res; 1981 Mar; 41(3):894-904. PubMed ID: 7459875
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Enhancing targeted radiotherapy by copper(II)diacetyl- bis(N4-methylthiosemicarbazone) using 2-deoxy-D-glucose.
    Aft RL; Lewis JS; Zhang F; Kim J; Welch MJ
    Cancer Res; 2003 Sep; 63(17):5496-504. PubMed ID: 14500386
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
    Buroker TR; Moertel CG; Fleming TR; Everson LK; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Klaassen DJ; Laurie JA
    J Clin Oncol; 1985 Dec; 3(12):1624-31. PubMed ID: 2933492
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Treatment of intracranial rat glioma model with implant of radiosensitizer and biomodulator drug combined with external beam radiotherapy.
    Li Y; Owusu A; Lehnert S
    Int J Radiat Oncol Biol Phys; 2004 Feb; 58(2):519-27. PubMed ID: 14751523
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Unexpected synergy between N-phosphonacetyl-L-aspartate and cytidine against human tumor cells.
    Chan TC; Howell SB
    Eur J Cancer Clin Oncol; 1989 Apr; 25(4):721-7. PubMed ID: 2714348
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.